Hematologic Disorders

Jun 14, 2021| Posted in: Cancers, Hematologic Disorders, Treatment

Interim Data Gives Hope to Myelofibrosis Patients Facing Sup-Optimal Results from Ruxolitinib Alone

Peter Langmuir, MD, Group Vice President, Oncology Targeted…
Jun 11, 2021| Posted in: Congenital And Genetic Conditions, Drug Development, Hematologic Disorders, Metabolic Disorders, News, Treatment

FDA Approves Expanded Access of PNH Drug to Include Younger Patients

The U.S. Food and Drug Administration (FDA) has…
Jun 10, 2021| Posted in: Cancers, Drug Development, Hematologic Disorders, Neurology/Nervous System Diseases, Treatment

Cilta-Cel Continues to Show Promise as a Treatment for Progressive Multiple Myeloma

Mounzer Agha, MD, Director of the Mario Lemieux…
Jun 7, 2021| Posted in: Congenital And Genetic Conditions, Hematologic Disorders

FDA Approves First Ever Treatment for Rare Genetic Condition – Plasminogen Deficiency Type 1

The U.S. Food and Drug Administration (FDA) has…
May 14, 2021| Posted in: Drug Development, Hematologic Disorders, News, Treatment

FDA Approves Apellis’ Pegcetacoplan for Paroxysmal Nocturnal Hemoglobinuria (PNH)

The U.S. Food and Drug Administration (FDA) has…
May 14, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Hematologic Disorders

Memory Loss, Mood Disturbances, and Thrombotic Thrombocytopenic Purpura (TTP)

Spero R. Cataland, MD, Oncologist and Hematology Specialist…
Apr 28, 2021| Posted in: Hematologic Disorders, Treatment

Jehovah’s Witnesses and Plasma Exchange Alternatives

Shruti Chaturvedi, MBBS, MS, Assistant Professor of Medicine…
Apr 26, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Congenital And Genetic Conditions, Hematologic Disorders

More Education About Thrombotic Thrombocytopenic Purpura (TTP) Needed

Dr Long Zheng, from the University of Kansas…
Apr 16, 2021| Posted in: Diagnosis, Hematologic Disorders

What is Paroxysmal Nocturnal Hemoglobinuria?

Cedric Francois, MD, PhD, Co-Founder & CEO of…
Apr 16, 2021| Posted in: Autoimmune / Autoinflammatory Disorders, Hematologic Disorders

Two Things to Look For While Managing a TTP Patient

Shruti Chaturvedi, MBBS, MS, Assistant Professor of Medicine…

CME Program: Gaucher Disease Highlights from WORLDSymposium 2020

Neal Weinreb, MD, FACP highlights the latest information about Gaucher disease from WORLDSymposium and provides expert analysis of its clinical relevance to help health care providers better care for patients with this rare disease.

TTR Amyloidosis CME Program

Morie A Gertz, MD, MACP provides an overview of TTR Amyloidosis – including how to shorten individuals’ diagnostic journey and the time till they access treatment which might improve their quality of life or even prevent disease progression – through these brief courses that are certified for CME credit.

Rare Disease Clinical Trials CME Program

Learn about clinical trials and rare diseases through these brief courses that are certified for CME and CNE credit.
  • Heather Lau, MD, MS, NYU School of Medicine, New York, NY
  • Morie A Gertz, MD, Mayo Clinic, Rochester, MN
  • Timothy Craig, DO, Penn State University, Hershey, PA
  • Eric T. Wong, MD, Harvard Medical School, Boston, MA

Hematologic Disorders

Topics